To explore the interactions between the intestinal epithelial barrier and gut microbiota in the context of sepsis, and to summarize emerging therapeutic strategies targeting gut function, including specific interventions and their potential impacts.
Approach:
Key Findings:
Sepsis is characterized by a dysregulated host response to infection, leading to high mortality rates.
The intestinal epithelial barrier (IEB) plays a crucial role in maintaining immune homeostasis; its dysfunction can exacerbate sepsis.
Gut microbiota dysbiosis can impair the IEB, leading to systemic inflammation and immunosuppression.
The interaction between the IEB, gut microbiota, and immune system is critical in the progression of sepsis.
Interpretation:
The review highlights the importance of the gut barrier and microbiota in sepsis pathogenesis and suggests that targeting gut function, through specific therapeutic interventions, may offer new avenues for treatment.
Limitations:
The precise mechanisms of gut and microbiota interactions in sepsis are not fully elucidated, which may hinder the development of effective therapies.
Current therapeutic strategies targeting gut function are still under investigation, limiting their immediate clinical application.
Conclusion:
Understanding the interplay between the gut barrier and microbiota may provide insights into novel treatment strategies for sepsis.
